Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

E£5.54As of Sun 8 Nov 2026, 12:00 UTC
EGX:RMDAHealthcare
Country Egypt
PE (Fwd) •••
TSR 7Y CAGR 19.33%
Div yield 0.73%
ROE 14.95%
Pharmaceutical Preparations
Beta (5Y) 0.53
PE TTM 37.18
TSR TTM 69.95%
Mkt cap E£11.26B
ROIC 15.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£5.32
(3.93%)
(92.60%)
Hold 5|8|8|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
0.06
0.07
0.07
0.07
24.48%
36.09%
24.61%
12.36%
RevenueE£M
486.0
479.4
497.3
494.7
2.93%
4.25%
3.89%
4.54%
Peers (US$207.5M)
Cap (US$)
PE
209.9M
16.81x
Capital
TTM
5Y
10Y
Leveragex
1.796
0.068
0.065
EBIT/Intx
0.253
0.211
0.186
Own earn%
(50.94)
(18.83)
(8.40)
Sh yield%
8.25
15.93
15.04
Owners
Insiders/Inst%
14.50
31.11
Short interest%
4.50
SBC / revenue%
2.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
14